Switching Between GLP-1 Medications Understanding semaglutides clearance timeline matters when switching to or from other medications
After 10% or greater body weight loss, a 4-week PPI taper with symptom monitoring is reasonable and aligns with AGA recommendations against unnecessary long-term acid suppression [11]
Inform all healthcare professionals involved in your care about both medications, including pharmacists, dentists, and specialists
When calories drop, nutrition matters more
The FDA has recognized allulose as Generally Recognized as Safe (GRAS) and under enforcement discretion permits its exclusion from total and added sugars labeling, though it still counts toward Total Carbohydrate on nutrition labels
Beyond weight loss, these medications are game-changers for managing type 2 diabetes